SCHEMBL443124

SCHEMBL443124

CCC1(CC)CCNCC1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.31
TSHR P16473 1/20 0.30
KDM4E B2RXH2 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14753709 0.89 CXCR4 (0.32)
SCHEMBL321360 0.84 KDM4E (0.30) KDM4EKMT2A
SCHEMBL14102785 0.84
SCHEMBL2279102 0.82
SCHEMBL24993055 0.80
SCHEMBL12589185 0.80 SLC6A2 (0.35)
SCHEMBL22020558 0.80
SCHEMBL16547437 0.80
SCHEMBL14536280 0.80 HSD17B10 (0.32)
SCHEMBL14367707 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 534 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4482453-B1 COLORANT COMPOSITION COMPRISING LEUCOINDIGO FOR COLORING FIBERS AND FABRICS LABORATOIRE BIOSTHETIQUE KOSMETIK GMBH & CO KG (DE) 2026-04-08 EP claimed
US-20250154359-A1 COLORANT COMPOSITION COMPRISING LEUCOINDIGO FOR COLORING FIBERS AND FABRICS LABORATOIRE BIOSTHETIQUE KOSMETIK GMBH & CO. KG (DE) 2025-05-15 US claimed
CN-119874922-A Method for preparing human HLA specific antibody detection standard by using protein A immunoadsorption waste liquid 广州嘉检医学检测有限公司 2025-04-25 CN claimed
CN-118947769-A Gelatin-based frozen gel and preparation method and application thereof 南京工业大学 2024-11-15 CN claimed
CN-116593714-A Membrane strip for detecting walnut allergen IgE, preparation method thereof and kit 江苏浩欧博生物医药股份有限公司 2023-08-15 CN claimed
CN-114933647-B Preparation method of insulin crystal and product 重庆宸安生物制药有限公司 2023-06-06 CN claimed
CN-115863544-B Positive electrode plate and preparation method and application thereof 江苏正力新能电池技术有限公司 2023-05-23 CN claimed
CN-115863544-A Positive pole piece and preparation method and application thereof 江苏正力新能电池技术有限公司 2023-03-28 CN claimed
CN-111122682-B Method for identifying traditional Chinese medicine lizard and fake product thereof, namely hylocereus undatus 山西医科大学 2022-11-11 CN claimed
CN-114933647-A Preparation method of insulin crystal and product 重庆宸安生物制药有限公司 2022-08-23 CN claimed
CN-113358590-B High-efficiency tripodia magnesium ion DNA enzyme walking machine and application thereof in detecting antibiotics 湖北师范大学 2022-07-12 CN claimed
CN-112816414-B Alkaline phosphatase detection kit based on dual-emission lanthanide MOF and detection method 武汉大学 2022-07-05 CN claimed
EP-3384289-B1 METHOD OF ANALYSIS OF PROTEINS IN URINE INST BIOCHEMII I BIOFIZYKI POLSKIEJ AKADEMII NAUK (PL) 2022-06-01 EP claimed
CN-122081478-A Hybrid probe mixed solution for radiation biological dose detection and preparation method and product thereof 2026-05-26 CN disclosed
US-20260139017-A1 COMPOSITIONS AND METHODS USING REELIN IN ALZHEIMER'S DISEASE THE GENERAL HOSPITAL CORP (US) 2026-05-21 US disclosed
US-12629395-B2 Composition for inhibiting trypsin activity containing as active ingredient bacterium belonging to genus Paraprevotella RIKEN (JP) 2026-05-19 US disclosed
US-20090062297-A1 Hydroxyalkylarylamide Derivatives MERCK SHARP & DOHME CORP. 2009-03-05 US disclosed
US-7244723-B2 Substituted furopyrimidinones as a mitotic kinesin inhibitors MERCK & CO., INC. (US) 2007-07-17 US disclosed
US-20070129309-A1 Conjugates useful in the treatment of prostate cancer BRADY STEPHEN F 2007-06-07 US disclosed
US-5391556-A Thrombin inhibitors KARL THOMAE GMBH (DE) 1995-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062297-A1 Hydroxyalkylarylamide Derivatives AADAC, HDAC5, HDAC3 OPRM1 4781/4885TSHR 691/4885KDM4E 313/4885
US-12629395-B2 Composition for inhibiting trypsin activity containing as active ingredient bacterium belonging to genus Paraprevotella CTRL, VIP, SI OPRM1 3745/4885TSHR 3863/4885KDM4E 1645/4885
US-20070129309-A1 Conjugates useful in the treatment of prostate cancer BPHL, KLK3, DNPEP OPRM1 1966/4885TSHR 3732/4885KDM4E 1171/4885
US-20260139017-A1 COMPOSITIONS AND METHODS USING REELIN IN ALZHEIMER'S DISEASE PSEN1, PRNP, APP OPRM1 1033/4885TSHR 448/4885KDM4E 3744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.